Pee Safe Secures $32M to Expand Women’s Hygiene Business
Pee Safe, a pioneering women’s hygiene and wellness startup based in Gurugram, has recently secured $32 million in a Series C funding round led by OrbiMed. This significant investment is a testament to Pee Safe’s commitment to addressing hygiene gaps and expanding its footprint in the women’s healthcare sector.
The Journey of Pee Safe
Founded by Vikas Bagaria and Rithish Kumar, Pee Safe started by popularizing toilet seat sanitiser sprays in India. Over the years, it has evolved into a comprehensive consumer healthcare brand, offering products in feminine and intimate hygiene, personal care, grooming, and wellness. This expansion reflects a strategic shift from being a single-product company to a broader healthcare brand.
Investment Details and Strategic Goals
The funding round, which includes both primary capital and secondary share sales, allows early investors to partially exit while providing growth capital for Pee Safe. OrbiMed, a healthcare-focused private equity firm managing about $20 billion, has taken board seats at Pee Safe, with Dr. Sunny Sharma and Sumona Chakraborty joining the board. This partnership aims to bolster Pee Safe’s omnichannel growth engine, especially as consumer discovery shifts towards instant delivery platforms.
Scaling Profitably in a Competitive Market
Pee Safe has achieved an annualized net revenue run rate of over Rs 150 crore while maintaining profitability—a rarity among Indian direct-to-consumer (D2C) brands. This success is attributed to disciplined execution and a focus on profitable scaling, setting Pee Safe apart in a market often dominated by large FMCG players and well-funded startups.
Deployment of Fresh Capital
The new capital will be primarily used to:
- Expand offline retail distribution
- Strengthen brand-led marketing
- Accelerate growth across quick commerce platforms and major e-commerce marketplaces
Pee Safe currently boasts an omnichannel presence across more than 50,000 offline retail touchpoints in over 100 cities, along with distribution through leading online platforms and exports to 23 international markets.
The Growing Interest in Consumer Healthcare
For OrbiMed, the investment in Pee Safe reflects a growing interest in consumer healthcare brands that intersect wellness, preventive health, and everyday personal care. Dr. Sunny Sharma, Senior Managing Director at OrbiMed Asia, noted the significant headroom for growth as hygiene and wellness adoption deepens across India.
Challenges and Opportunities
While investors are becoming more selective about backing D2C companies, Pee Safe’s positioning as a category creator in toilet hygiene and its expansion into adjacent women-focused healthcare segments have helped it stand out. The company’s focus on disciplined execution has allowed it to scale profitably, challenging long-standing taboos and addressing underserved women’s health categories.
The Future of Women’s Hygiene
Pee Safe’s journey is an inspiring example of how startups can address critical gaps in the market while maintaining profitability. As the company continues to grow, it raises thought-provoking questions about the future of women’s hygiene and wellness in India. How can other startups emulate Pee Safe’s success? What role will consumer healthcare play in shaping the future of wellness?
By leveraging its robust brand and strategic partnerships, Pee Safe is well-positioned to lead the charge in transforming women’s hygiene and wellness, not just in India but globally. For more information on Pee Safe’s products and initiatives, visit their official website.
In conclusion, Pee Safe’s recent funding round is a significant milestone in its journey to becoming a leading player in the women’s hygiene sector. With strategic investments and a clear focus on growth, Pee Safe is poised to make a lasting impact on women’s health and wellness.
